R Retnakaran, B Zinman - The Lancet, 2008 - Elsevier Type 1 diabetes is associated with a substantially increased risk of cardiovascular disease that
might not always be appreciated in view of the fairly young age of patients with this
condition. In fact, in type 1 diabetes, the heart is subject to a variety of pathological insults, ... Cited by 19 - Related articles - All 9 versions
I Raz, PWF Wilson, K Strojek, I Kowalska, V Bozikov … - Diabetes Care, 2009 - Am Diabetes Assoc RESULTS—A total of 1,115 patients were randomly assigned (PRANDIAL n = 557; BASAL n
= 558), and the mean patient participation after randomization was 963 days (range 1–1,687
days). The trial was stopped for lack of efficacy. Risks of first combined adjudicated ... Cited by 18 - Related articles - All 4 versions
E Mannucci, M Monami, C Lamanna, F Gori, N … - Nutrition, Metabolism and …, 2009 - Elsevier Five studies (17,267 and 15,362 patients in the intensive and conventional therapy groups,
respectively) were included. Intensive treatment, which reduced mean HbA1c by 0.9% on
average, was associated with a significant reduction of incident cardiovascular events ... Cited by 6 - Related articles - All 4 versions
D Lee, X Sui, TS Church, IM Lee, SN Blair - Diabetes Care, 2009 - Am Diabetes Assoc RESULTS—Of the men, 3,612 (39,610 person-years) and 477 (101,419 person-years) developed
IFG and type 2 diabetes, respectively. Compared with the least fit 20% in multivariate
analyses, IFG and type 2 diabetes risks in the most fit 20% were 14 and 52% lower, ... Cited by 5 - Related articles - All 3 versions
- ►diabetesjournals.org A Ceriello - Diabetes Care, 2009 - Am Diabetes Assoc In the recent HEART2D (Hyperglycemia and its Effect After Acute Myocardial Infarction on Cardiovascular
Outcomes in Patients with Type 2 Diabetes Mellitus) study, published in this issue of Diabetes
Care, Raz et al. (1) try to answer a hotly debated question of the last 10 years: is ... Cited by 3 - Related articles - All 3 versions
S Akalin, K Berntorp, A Ceriello, AK Das, … - … Journal of Clinical …, 2009 - interscience.wiley.com Background: There is compelling evidence showing that achieving good glycaemic control reduces
the risk of microvascular complications in people with type 1 and type 2 diabetes. Likewise, there
is clear evidence to show that achieving good glycaemic control reduces the risk of ... Cited by 2 - Related articles - All 3 versions
M Rewers - Diabetes Care, 2008 - Am Diabetes Assoc The excess mortality among people with diabetes and the role of cardiovascular disease
(CVD) in shortening their lives have been recognized for decades (1–3). Recent studies suggest
that all-cause mortality (4) and CVD incidence among people with diabetes (5) are ... Cited by 1 - Related articles - All 5 versions
- ►ncdp.com [PDF] TM Dall, SE Mann, Y Zhang, WW Quick, RF … - Population Health …, 2009 - liebertonline.com The objective was to estimate the economic costs of diagnosed type 1 (T1DM) and type 2
(T2DM) diabetes mellitus in the United States in 2007. Medical claims were analyzed to estimate
the proportion of diagnosed diabetes cases and excess medical costs by diabetes type. ... Cited by 2 - Related articles - All 9 versions
G Schernthaner - International Journal of Clinical Practice, 2009 - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ... Related articles - All 3 versions
A Thomas, M Schönauer, F Achermann, O … - Diabetes Technology …, 2009 - liebertonline.com Andreas Thomas, Ph.D., 1 Martin Schönauer, MD, 2 Frank Achermann, MD, 3 ... Oliver
Schnell, MD, 4 Markolf Hanefeld, MD, 5 Hans-Jürgen Ziegelasch, MD, 6 ... John
Mastrototaro, Ph.D., 7 and Lutz Heinemann, Ph.D. 8 ... Abstract Measuring the ... Related articles - All 2 versions
